AMERICAN SOCIETY OF DIAGNOSTIC & INTERVENTIONAL NEPHROLOGY (EIN 621824027) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2000

Legal Domicile

Principal Officer

MARY LEA NATIONS

Phone

6019242220

Tax Period

2024-01-01 to 2024-12-31

AMERICAN SOCIETY OF DIAGNOSTIC & INTERVENTIONAL NEPHROLOGY, founded in 2000, is a small nonprofit in the Education sector that reported $820K in total revenue in fiscal year 2024. Revenue surged 60% from the prior year, signaling strong growth momentum. The organization ran a surplus of $212K, a strong 26% operating margin.

Mission

TO PROMOTE EXCELLENCE IN DIALYSIS CARE TO IMPROVE OUTCOMES FOR PATIENTS WITH KIDNEY DISEASE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $513,396

Program Service Revenue $209,238

Investment Income $96,960

Other Revenue $0

TOTAL REVENUE $819,594

Expense Breakdown

Grants Paid $40,450

Salaries & Benefits $192,000

Fundraising Expenses $0

Program Expenses $557,026

Other Expenses $375,643

TOTAL EXPENSES $608,093

Year-over-Year Comparison

	2024	2023	Change
Revenue	$819,594	$510,681	+0.6%
Expenses	$608,093	$547,582	+0.1%
Net Income	$211,501	$-36,901	-6.7%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

100

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$192,000

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BHARAT SACHDEVA MD	PRESIDENT	2.00	Officer Director	$0	$0	$0
ADRIAN SEQUEIRA MD	PRESIDENT ELECT	2.00	Officer Director	$0	$0	$0
AMY DWYER MD	SECRETARY/TREASURER	2.00	Officer Director	$0	$0	$0
VANDANA DUA NIYYAR MD	PAST PRESIDENT	2.00	Officer Director	$0	$0	$0
AMMAR ALMEHMI MD	COUNCILOR	2.00	Director	$0	$0	$0
SARAVANAN BALA MD	COUNCILOR	2.00	Director	$0	$0	$0
JIE CUI MD	COUNCILOR	2.00	Director	$0	$0	$0
DALIA DAWOUD MD	COUNCILOR	2.00	Director	$0	$0	$0
NEGHAE MAWLA MD	COUNCILOR	2.00	Director	$0	$0	$0
BHARVI OZA-GAJERA MD	COUNCILOR	2.00	Director	$0	$0	$0
KARTHIK RAMANI MD	COUNCILOR	2.00	Director	$0	$0	$0
FOREST RAWLS CCHT-A FNKF	COUNCILOR	2.00	Director	$0	$0	$0
AISHA SHAIKH MD	COUNCILOR	2.00	Director	$0	$0	$0
MUKESH SHARMA MD	COUNCILOR	2.00	Director	$0	$0	$0
TZE-WOEI TAN MD	COUNCILOR	2.00	Director	$0	$0	$0
ADINA VOICULESCU MD	COUNCILOR	2.00	Director	$0	$0	$0
LOAY SALMAN MD	COUNCILOR	2.00	Director	$0	$0	$0
MARY LEA NATIONS	EXECUTIVE DIRECTOR	40.00	Officer	$192,000	$0	$192,000

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$819,594	$608,093	$1,989,824	$211,501
2023	$510,681	$547,582	$1,642,451	$-36,901
2022	$330,554	$377,620	$1,367,087	$-47,066
2021	$461,902	$313,287	$1,525,466	$148,615
2020	$571,869	$496,591	$1,339,164	$75,278
2019	$589,024	$429,746	$1,223,247	$159,278
2018	$393,631	$387,805	$1,020,444	$5,826

AMERICAN SOCIETY OF DIAGNOSTIC & INTERVENTIONAL NEPHROLOGY